Faith E. Fletcher, PhD, MA Assistant Professor
Division of Community Health Sciences
University of Illinois at Chicago
Recorded February 17, 2016
Pre Exposure Prophylaxis (PrEP) is a new HIV prevention strategy approved by the Food and Drug Administration for use by uninfected, high-risk adult populations. PrEP’s potential as an HIV preventive strategy/biomedical method for adolescents is unknown. The presentation will present preliminary results from a study that examined benefits, barriers, and ethical concerns associated with Pre-exposure Prophylaxis (PrEP) utilization and clinical trial participation among African American adolescent girls. Study findings have the potential to generate evidence-based data to inform HIV research ethics practices and increase just and fair access to HIV scientific advances.
This lecture was part of the 2015-2016 Bioethics Brownbag & Webinar Series, presented by the
Center for Ethics.